Clinical Trials on Hypertension, Pulmonary Artery in Ireland
Total 589 results
-
Broncus TechnologiesUnknownEmphysemaUnited States, Spain, Australia, Canada, Ireland, United Kingdom, Austria, Brazil, Germany, Netherlands
-
Boehringer IngelheimCompletedPulmonary FibrosisUnited States, Australia, Belgium, China, Czech Republic, France, Germany, India, Ireland, Israel, Italy, Japan, United Kingdom
-
TakedaCompletedHypertensionUnited States, Mexico, Chile, Peru
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Australia, Austria, Canada, Germany, Greece, New Zealand, Norway, Slovakia, South Africa, Sweden
-
Boehringer IngelheimCompletedPulmonary FibrosisSpain, Belgium, Canada, Germany, China, United Kingdom, Australia, Ireland, Italy, Mexico, Netherlands, Portugal, Argentina, France, Russian Federation, Greece, Czechia, Brazil, Bulgaria, Chile, Hungary
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
H. Lundbeck A/SCompletedSymptomatic Neurogenic Orthostatic HypotensionUnited States
-
Hoffmann-La RocheCompletedIdiopathic Pulmonary Fibrosis | Interstitial Lung DiseaseNetherlands, Ireland, France, Italy, Canada, Russian Federation
-
Forest LaboratoriesCompletedStage 2 Diastolic HypertensionUnited States, Puerto Rico
-
Galecto Biotech ABSyneos Health; bioRASI, LLCCompletedIdiopathic Pulmonary Fibrosis (IPF)United States, Spain, Israel, France, United Kingdom, Russian Federation, Australia, Italy, Germany, Canada, Belgium, Georgia, Ireland, Poland, Ukraine
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseUnited States, Peru, South Africa, Argentina, Mexico, Brazil, Chile, Colombia, Venezuela
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Germany, Ukraine, Spain, South Africa, Italy
-
Iantrek, Inc.Enrolling by invitationOpen Angle GlaucomaUnited States
-
Boston Scientific CorporationCompletedAtherosclerosis | Peripheral Artery Disease | Plaque, Atherosclerotic | Artery Diseases, Peripheral | Occlusive Arterial DiseaseUnited States, Belgium, Canada, Japan, Austria, New Zealand
-
AstraZenecaRecruitingCOPD (Chronic Obstructive Pulmonary Disease)France, Denmark, Italy, Spain, United States, Canada, Argentina, Japan, Colombia, Germany, Peru, Brazil, China, India, Thailand, Austria, Serbia, Malaysia, Philippines, Poland, Taiwan, Greece, Norway, Sweden, Mexico, Romania, Korea, Republic... and more
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Canada, Germany
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Australia, France, Romania, Finland, Taiwan, Bulgaria, Estonia, Canada, Netherlands, Philippines, South Africa, Sweden, Spain, Singapore, Austria, Germany, Latvia, New Zealand, China, Ukraine, Thailand, Greece, United Kingdom and more
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructivePuerto Rico, United States, Australia, Argentina, France, Germany, Japan, Netherlands, Russian Federation, Spain, Ukraine, Finland, Czechia, Poland, Belgium, Chile, Peru, South Africa, Sweden, Thailand, Israel, Korea, Republic of, C... and more
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Puerto Rico
-
The University of QueenslandUniversity of Copenhagen; Erasmus Medical Center; Monash University; Hôpital Cochin and other collaboratorsRecruitingPulmonary Disease Due to Mycobacteria (Diagnosis)Australia, Canada, Denmark, France, Ireland, Netherlands, New Zealand, United Kingdom, Singapore
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Germany, Japan, Russian Federation, Chile, Poland, Mexico, Estonia, Korea, Republic of, Philippines
-
Daiichi Sankyo, Inc.Completed
-
Forest LaboratoriesCompletedHypertensionUnited States
-
Daiichi Sankyo, Inc.Completed
-
Hoffmann-La RocheCompletedIdiopathic Pulmonary FibrosisGermany, United Kingdom, Ireland, France, Austria, Denmark, Finland, Italy, Norway, Sweden
-
ActelionCompletedIdiopathic Pulmonary FibrosisUnited States, France, Spain, Korea, Republic of, United Kingdom, Belgium, Japan, Australia, Canada, Czech Republic, Germany, Ireland, Israel, Italy, Switzerland
-
InspireMDRecruitingCarotid Artery StenosisUnited States, Poland
-
NovartisCompletedCOPDUnited States, Argentina, Germany, Spain, Canada, India, Turkey, Sweden, Italy
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Canada, Germany, Hungary, Korea, Republic of, Mexico, Poland, Russian Federation, Spain, Taiwan
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease | COPD | Moderate to Very Severe COPDUnited States, Canada
-
Somahlution LLCActive, not recruitingCardiovascular Diseases | Coronary Artery DiseaseSpain, Austria, Ireland, Switzerland, Germany, Italy, Turkey, United Kingdom
-
Forest LaboratoriesCompletedHypertensionUnited States
-
Nerre Therapeutics Ltd.Pharm-Olam InternationalActive, not recruitingCough | Idiopathic Pulmonary FibrosisUnited States, United Kingdom, Netherlands
-
Daiichi Sankyo, Inc.Completed
-
Momenta Pharmaceuticals, Inc.CompletedCoronary Artery Disease (CAD)United States, Canada
-
Kent Hospital, Rhode IslandGilead SciencesCompletedMyocardial Ischemia | Ventricular Premature ComplexesUnited States
-
McMaster UniversityCanadian Institutes of Health Research (CIHR)CompletedDeep Vein Thrombosis | Pulmonary EmbolismUnited States, Canada, Ireland, United Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Australia, Argentina, Germany, Spain, South Africa, Mexico, Peru, Netherlands, Canada, United Kingdom, Denmark, Chile, Italy, Sweden
-
PfizerTerminatedDiabetes Mellitus | Chronic Obstructive Pulmonary DiseaseUnited States, Canada, Brazil, Costa Rica, Germany
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Russian Federation, Chile, South Africa, Romania, Mexico, Norway
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Germany, Romania, Russian Federation, Spain, Bulgaria, Canada, Hungary, Argentina
-
Forest LaboratoriesMylan LaboratoriesTerminated
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Argentina, Australia, Germany, Estonia, Chile, Netherlands, Peru, South Africa, Sweden, Mexico, United Kingdom, Italy, Philippines, Canada
-
NovartisIntegrium; Great Lakes Drug Development, Inc.CompletedHypertensionUnited States, Iceland
-
Boehringer IngelheimCompletedPulmonary FibrosisArgentina, Australia, Belgium, Brazil, Bulgaria, Canada, Chile, China, Czech Republic, France, Germany, Greece, Hungary, Ireland, Italy, Korea, Republic of, Mexico, Netherlands, Portugal, Russian Federation, South Africa, Spain, Taiwan and more
-
Wake Forest University Health SciencesTerminated
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)Germany, Colombia, India, Korea, Republic of, Poland, Romania, South Africa, Italy, Austria, Belgium, Croatia, Estonia, Hungary, Russian Federation, Taiwan, Turkey, Japan, Spain, Sweden, United Kingdom, China, Thailand, Canada, Hong Kong and more
-
Chelsea TherapeuticsChiltern International Inc.CompletedA Clinical Study for Patients With Neurogenic Orthostatic Hypotension (NOH) Using Droxidopa (NOH301)Primary Autonomic Failure | Dopamine Beta Hydroxylase Deficiency | Symptomatic Neurogenic Orthostatic Hypotension (NOH) | Non-diabetic NeuropathyUnited States, Canada
-
Boehringer IngelheimCompletedIdiopathic Pulmonary FibrosisUnited States, Spain, Korea, Republic of, Belgium, Australia, United Kingdom, Canada, China, Germany, Japan, Turkey, France, Ireland, Italy, Israel, Netherlands, Portugal, Greece, India, Czechia, Chile, Finland, Mexico, Russian Federation
-
Vermillion, Inc.CompletedPeripheral Artery DiseaseUnited States